CPI-613 is a non-redox active lipoate derivative that acts as a selective inhibitor mitochondrial enzymes pyruvate dehydrogenase (PD H) and α-ketoglutarate dehydrogenase. In vitro, CPI-613 dose-dependently and efficiently kills H460 human lung cancer

Numéro d'article : BIOV9464-50
Unité de mesure : 50 MG
https://grogg-prod.braintec.cloud/web/image/product.template/929131/image_1920?unique=60a61f1

442.00 CHF 442.0 CHF 442.00 CHF

442.00 CHF

Not Available For Sale

    Cette combinaison n'existe pas.

    Délai de livraison actuel sur demande

    Fabricant : BIOVISION
    Numéro du fabricant : 9464-50
    Température de stockage : Freezer (-20)

    CPI-613 is a non-redox active lipoate derivative that acts as a selective inhibitor mitochondrial enzymes pyruvate dehydrogenase (PD H) and α-ketoglutarate dehydrogenase. In vitro, CPI-613 dose-dependently and efficiently kills H460 human lung cancer